Form 8-K - Current report:
SEC Accession No. 0001140361-22-018655
Filing Date
2022-05-11
Accepted
2022-05-11 16:16:06
Documents
15
Period of Report
2022-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10037508_8k.htm   iXBRL 8-K 32039
2 EXHIBIT 99.1 brhc10037508_ex99-1.htm EX-99.1 185452
7 image0.jpg GRAPHIC 6839
  Complete submission text file 0001140361-22-018655.txt   419715

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA adma-20220511.xsd EX-101.SCH 4377
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adma-20220511_def.xml EX-101.DEF 17551
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20220511_lab.xml EX-101.LAB 27040
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adma-20220511_pre.xml EX-101.PRE 19730
9 EXTRACTED XBRL INSTANCE DOCUMENT brhc10037508_8k_htm.xml XML 6009
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

EIN.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 22913918
SIC: 2836 Biological Products, (No Diagnostic Substances)